These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 9915850)

  • 1. CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28.
    Slavik JM; Hutchcroft JE; Bierer BE
    J Biol Chem; 1999 Jan; 274(5):3116-24. PubMed ID: 9915850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncoupling activation-dependent HS1 phosphorylation from nuclear factor of activated T cells transcriptional activation in Jurkat T cells: differential signaling through CD3 and the costimulatory receptors CD2 and CD28.
    Hutchcroft JE; Slavik JM; Lin H; Watanabe T; Bierer BE
    J Immunol; 1998 Nov; 161(9):4506-12. PubMed ID: 9794375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion.
    Ueda Y; Levine BL; Huang ML; Freeman GJ; Nadler LM; June CH; Ward SG
    Int Immunol; 1995 Jun; 7(6):957-66. PubMed ID: 7577804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD28 co-stimulatory regimes differ in their dependence on phosphatidylinositol 3-kinase: common co-signals induced by CD80 and CD86.
    Cefai D; Cai YC; Hu H; Rudd C
    Int Immunol; 1996 Oct; 8(10):1609-16. PubMed ID: 8921441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-independent Th2 cell differentiation by stimulation of CD28: regulation via IL-4 gene expression and mitogen-activated protein kinase activation.
    Skapenko A; Lipsky PE; Kraetsch HG; Kalden JR; Schulze-Koops H
    J Immunol; 2001 Apr; 166(7):4283-92. PubMed ID: 11254680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T cells: phosphatidylinositol 3-kinase association to CD28 and cytokine production.
    Ghiotto-Ragueneau M; Battifora M; Truneh A; Waterfield MD; Olive D
    Eur J Immunol; 1996 Jan; 26(1):34-41. PubMed ID: 8566081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line.
    Irvin BJ; Williams BL; Nilson AE; Maynor HO; Abraham RT
    Mol Cell Biol; 2000 Dec; 20(24):9149-61. PubMed ID: 11094067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.
    Caux C; Vanbervliet B; Massacrier C; Azuma M; Okumura K; Lanier LL; Banchereau J
    J Exp Med; 1994 Nov; 180(5):1841-7. PubMed ID: 7525840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro.
    Levine BL; Ueda Y; Craighead N; Huang ML; June CH
    Int Immunol; 1995 Jun; 7(6):891-904. PubMed ID: 7577797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD28 as a molecular amplifier extending TCR ligation and signaling capabilities.
    Michel F; Attal-Bonnefoy G; Mangino G; Mise-Omata S; Acuto O
    Immunity; 2001 Dec; 15(6):935-45. PubMed ID: 11754815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway.
    Shanafelt MC; Kang I; Barthold SW; Bockenstedt LK
    Infect Immun; 1998 Jan; 66(1):266-71. PubMed ID: 9423867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biased dependency of CD80 versus CD86 in the induction of transcription factors regulating the human IL-2 promoter.
    Olsson C; Michaëlsson E; Parra E; Pettersson U; Lando PA; Dohlsten M
    Int Immunol; 1998 Apr; 10(4):499-506. PubMed ID: 9620606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
    Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
    Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
    Broeren CP; Gray GS; Carreno BM; June CH
    J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells.
    Vandenberghe P; Freeman GJ; Nadler LM; Fletcher MC; Kamoun M; Turka LA; Ledbetter JA; Thompson CB; June CH
    J Exp Med; 1992 Apr; 175(4):951-60. PubMed ID: 1372649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.
    Kleinpeter P; Remy-Ziller C; Winter E; Gantzer M; Nourtier V; Kempf J; Hortelano J; Schmitt D; Schultz H; Geist M; Brua C; Hoffmann C; Schlesinger Y; Villeval D; Thioudellet C; Erbs P; Foloppe J; Silvestre N; Fend L; Quemeneur E; Marchand JB
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30918073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CD80 and CD86 on T cell cytokine production.
    Petro TM; Chen SS; Panther RB
    Immunol Invest; 1995 Nov; 24(6):965-76. PubMed ID: 8575841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential requirement for CD28/CTLA-4-CD80/CD86 interactions in drug-induced type 1 and type 2 immune responses to trinitrophenyl-ovalbumin.
    Nierkens S; Aalbers M; Bol M; Bleumink R; van Kooten P; Boon L; Pieters R
    J Immunol; 2005 Sep; 175(6):3707-14. PubMed ID: 16148116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.